{
    "2019-12-30": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Court orders Boston Scientific to complete $275M acquisition",
                "features": {
                    "keywords": [
                        "Boston Scientific",
                        "acquisition",
                        "court order"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "The Zacks Analyst Blog Highlights: Facebook, Alibaba, Mastercard, Abbott Laboratories and Philip Morris International",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Facebook",
                        "Alibaba",
                        "Mastercard",
                        "Abbott Laboratories",
                        "Philip Morris International"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "financial services",
                        "healthcare",
                        "consumer goods"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "The Zacks Analyst Blog Highlights: AbbVie, Abbott Labs, Allergan, Johnson & Johnson and Merck",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "AbbVie",
                        "Abbott Labs",
                        "Allergan",
                        "Johnson & Johnson",
                        "Merck"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}